Filter Results:
(4,370)
Show Results For
- All HBS Web
(4,370)
- People (14)
- News (1,532)
- Research (2,274)
- Events (1)
- Multimedia (155)
- Faculty Publications (1,786)
Show Results For
- All HBS Web
(4,370)
- People (14)
- News (1,532)
- Research (2,274)
- Events (1)
- Multimedia (155)
- Faculty Publications (1,786)
- 13 Oct 2016
- Video
The Crash and the Fix of Healthcare.gov
- March 2023
- Case
Roche: ESG and Access to Healthcare
By: George Serafeim, Susanna Gallani and Benjamin Maletta
In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first ESG investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that... View Details
Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Health Industry; Health Industry; Switzerland; North America; Europe; Asia; Latin America; Africa
Serafeim, George, Susanna Gallani, and Benjamin Maletta. "Roche: ESG and Access to Healthcare." Harvard Business School Case 123-075, March 2023.
- November 2005 (Revised November 2005)
- Case
Massachusetts General Hospital and the Enbrel Royalty
By: David S. Scharfstein and Darren R. Smart
Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well... View Details
Keywords: Valuation; Price; Investment Return; Capital; Value; Revenue; Health Care and Treatment; Health Industry; Health Industry; Massachusetts
Scharfstein, David S., and Darren R. Smart. "Massachusetts General Hospital and the Enbrel Royalty." Harvard Business School Case 206-075, November 2005. (Revised November 2005.)
- June 2023
- Supplement
Roche: ESG and Access to Healthcare
By: George Serafeim
In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first ESG investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that... View Details
Keywords: ESG (Environmental, Social, Governance) Performance; Sustainable Finance; Growth Strategy And Execution; Sustainability Targets; Impact Evaluation; Healthcare Access; Healthcare Innovation; Healthcare Systems; Healthcare Operations; Finance; Strategy; Health Testing and Trials; Health Care and Treatment; Growth Management; Measurement and Metrics; Innovation Strategy; Corporate Social Responsibility and Impact; Health Industry; Pharmaceutical Industry; Switzerland; North America; Europe; Asia; Latin America; Africa
Serafeim, George. "Roche: ESG and Access to Healthcare." Harvard Business School Multimedia/Video Supplement 123-713, June 2023.
- 16 Oct 2017
- Working Paper Summaries
Healthy Business? Managerial Education and Management in Healthcare
- October–December 2022
- Article
How Psychological Safety and Feeling Heard Relate to Burnout and Adaptation Amid Uncertainty
By: Michaela J. Kerrissey, Tuna Cem Hayirli, Aditi Bhanja, Nicholas Stark, James Hardy and Christopher Peabody
Background: Psychological safety—the belief that it is safe to speak up—is vital amid uncertainty, but its relationship to feeling heard is not well understood.
Purpose: The aims of this study were (a) to measure feeling heard and (b) to assess... View Details
Purpose: The aims of this study were (a) to measure feeling heard and (b) to assess... View Details
Keywords: Burnout; Crisis; Psychological Safety; Feeling Heard; Process Adaptation; Interpersonal Communication; Well-being; Health Care and Treatment; Adaptation
Kerrissey, Michaela J., Tuna Cem Hayirli, Aditi Bhanja, Nicholas Stark, James Hardy, and Christopher Peabody. "How Psychological Safety and Feeling Heard Relate to Burnout and Adaptation Amid Uncertainty." Health Care Management Review 47, no. 4 (October–December 2022): 308–316.
- January 2014 (Revised January 2014)
- Case
Henry Schein: Doing Well by Doing Good?
By: Rebecca Henderson, Raffaella Sadun, Aldo Sesia and Russell Eisenstat
Henry Schein Inc., a distributor of supplies to dentist, physician, and veterinary practices, had sales approaching $9 billion and employed nearly 16,000 people. The company had experienced impressive growth under the leadership of Stanley Bergman and his executive... View Details
Keywords: Leadership Development; Strategy Execution; Performance Management; Corporate Culture; Social Responsibility; Mergers ＆ Acquisitions; Joint Ventures; Partnerships; Health Care Industry; Healthcare Logistics Industry; Competitive Advantage; Strategy; Leadership; Global Strategy; Selection and Staffing; Management Style; Organizational Culture; Corporate Social Responsibility and Impact; Health Industry; Health Industry; China; Europe; United States
Henderson, Rebecca, Raffaella Sadun, Aldo Sesia, and Russell Eisenstat. "Henry Schein: Doing Well by Doing Good?" Harvard Business School Case 714-450, January 2014. (Revised January 2014.)
- November 2024
- Teaching Note
Martine Rothblatt and United Therapeutics: A Series of Implausible Dreams
By: Debora L. Spar and Julia M. Comeau
Teaching Note for HBS Case No. 323-039. In 1990, satellite expert and Sirius XM founder Martine Rothblatt was determined to save the life of her seven-year-old daughter, Jenesis, who was diagnosed with a terminal illness called Pulmonary Arterial Hypertension (PAH). At... View Details
Keywords: Pharmaceutical Companies; Technological And Scientific Innovation; Organ Donation; Health Care and Treatment; Health Disorders; Innovation and Invention; Growth and Development Strategy; Product Development; Medical Devices and Supplies Industry; Medical Devices and Supplies Industry; United States; District of Columbia
- September 2013 (Revised January 2016)
- Case
The Abraaj Group and the Acibadem Healthcare Investment (A)
By: Paul A. Gompers, Bora Uluduz and Firdevs Abacioglu
This case concerns the proposed buyout of Acibadem, a leading hospital chain in Turkey. Abraaj, a MENA region private equity firm, proposes to make its first investment in Turkey. The case highlights the role of Turkish health care reform in driving the value. The... View Details
Gompers, Paul A., Bora Uluduz, and Firdevs Abacioglu. "The Abraaj Group and the Acibadem Healthcare Investment (A)." Harvard Business School Case 214-021, September 2013. (Revised January 2016.)
- Web
Bringing the Next Pandemic Vaccine to Your Doorstep with MIMIX - Blog: Health Supplement
Blog Blog Health Care and Life Science at HBS Filter Results Arrow Down Arrow Up Read posts from Author Alumni Author Blavatnik Fellow Author Blavatnik Fellowship Team Author... View Details
- 27 Sep 2013
- Working Paper Summaries
The Impact of Conformance and Experiential Quality on Healthcare Cost and Clinical Performance
- 15 Mar 2019
- News
Targeting cancer and careers: Precision Medicine
- June 2018
- Teaching Note
Sandra Brown Goes Digital
By: Rosabeth Moss Kanter and Jonathan Cohen
As a middle manager at a biotechnology company, Sandra Brown harnessed digital tools and social media to engage others and build campaigns for change in the company. This Teaching Note presents strategies for teaching the Sandra Brown case series, which follows Brown's... View Details
- November 2018
- Case
David Hysong and SHEPHERD Therapeutics
By: Ananth Raman, John Masko and Aldo Sesia
In 2016, David Hysong, at age 27, found out he had a rare, incurable cancer. Rather than wait around to die, Hysong, a recent graduate of Harvard Divinity School, decided to launch a biotechnology company called Shepherd Therapeutics to development treatments for his... View Details
- June 2005
- Case
Growth and Profitability at Fresenius
By: Joel Podolny, Vincent Dessain, Monika Stachowiak and Anders Sjoman
In March 2005, Mark Schneider, CEO of Fresenius, is considering the group's strategic and organizational future. The highly decentralized 7 billion euro German health care group is active in three different business units, with the largest, FMC AG, listed separately... View Details
Keywords: Globalized Firms and Management; Diversification; Organizational Structure; Growth and Development Strategy; Health Industry; Germany
Podolny, Joel, Vincent Dessain, Monika Stachowiak, and Anders Sjoman. "Growth and Profitability at Fresenius." Harvard Business School Case 405-083, June 2005.
The New Negotiation Over Job Benefits and Perks in post-Covid Hybrid Work
As organizations consider what a return to the office looks like, some employees say they would be willing to forgo traditional perks like health care and pay for access to office space. View Details
- 04 Apr 2014
- News
What It Really Takes to Listen to Patients
- 01 Jul 2020
- News